Conference Banner

International Congress on Tissue Engineering & Regenerative Medicine

International Congress on Tissue Engineering & Regenerative Medicine

📍

Online

📅

December 4, 5, 6 2021

“Next-Generation Strategies in Regenerative Medicine”

Conference Overview

"The International Congress on Tissue Engineering & Regenerative Medicine brings together leading scientists, clinicians, engineers, and industry experts from around the world to explore the latest advances shaping the future of regenerative healthcare. This congress serves as a premier interdisciplinary platform to exchange knowledge, present cutting-edge research, and foster collaborations across academia, clinical practice, and industry. The scientific program will highlight recent breakthroughs in tissue engineering, stem cell research, biomaterials, bio-fabrication, and regenerative therapies, with a strong emphasis on translational and clinical applications. Through keynote lectures, plenary sessions, symposia, workshops, and poster presentations, participants will gain insights into emerging technologies, innovative therapeutic strategies, and the challenges of moving regenerative solutions from bench to bedside. In addition, the congress will address regulatory, ethical, and commercialization aspects of regenerative medicine, providing a comprehensive perspective on the field’s rapid evolution. The event aims to inspire innovation, encourage multidisciplinary collaboration, and accelerate the development of safe and effective regenerative therapies for improved patient outcomes."

Global Platform bringing together renowned researchers, clinicians, engineers, and industry leaders in tissue engineering and regenerative medicine
Keynote & Plenary Lectures by internationally recognized experts showcasing groundbreaking discoveries and future directions
Scientific Sessions covering stem cells, biomaterials, bio-fabrication, 3D bio-printing, Mechanobiology, and regenerative therapies
Translational & Clinical Focus emphasizing bench-to-bedside research and real-world clinical applications
Workshops & Symposia offering hands-on learning, emerging technologies, and methodological advancements
Young Investigator & Student Sessions promoting early-career researchers and innovative ideas
Poster Presentations enabling in-depth scientific discussion and networking
Awards & Recognitions for outstanding research, oral presentations, and posters
Networking & Collaboration Opportunities with academia, hospitals, research institutes, and industry partners
Industry & Innovation Showcase highlighting commercialization, regulatory insights, and startup initiatives

Featured Keynote Speakers

Soheila Naderi Gharahgheshlagh

Iran University of Medical Sciences, Iran

Soheila Naderi Gharahgheshlagh

Soheila Naderi Gharahgheshlagh

Iran University of Medical Sciences, Iran

Dr Naderi is working on an integrated multidisciplinary regenerative medicine approach and advanced methodologies to create advanced wound dressings. Her research interests focus on Marine and fish-derived materials for developing regenerative constructs. She has presented at many national and international conferences in the field of tissue engineering and has acted as a referee for high-profile peer-reviewed journals.

Anine Crous

University of Johannesburg, South Africa)

Anine Crous

Anine Crous

University of Johannesburg, South Africa)

Dr. Anine Crous is a senior lecturer and NRF Y-rated researcher at the University of Johannesburg’s Laser Research Centre. Her research encompasses photobiomodulation, stem cells, photodynamic therapy, and cancer stem cells, with an emphasis on 3D cell culture and organoid models. She has published over 30 academic works and supervises master's, PhD, and postdoctoral researchers. Dr. Crous serves as Membership Director of WALT and Chair of OPTICA’s Therapeutic Laser Applications group. She has received multiple research grants and is recognized for her leadership in basic science focussing on regenerative medicine and stem cell-based therapies, advancing innovative approaches in personalized healthcare.

Darwin Eton

Vasogenesis Inc, United States

Darwin Eton

Darwin Eton

Vasogenesis Inc, United States

Dr Darwin Eton is a Distinguished Fellow of the Society of Vascular Surgery. He graduated from the Massachusetts Institute of Technology (B.Sc, MSc.) in 1978 and New York University Medical School (M.D.) in 1982. He initiated this project in 1999 at University of Miami where he was Professor and Chief of Vascular Surgery. He continued the clinical work as Professor of Surgery at the University of Chicago. This project won the Cures Within Reach Award in 2016. The proceeds were used to fund a confirmatory study at University of Illinois at Chicago, where Dr Eton had a Voluntary Professor appointment in Surgery. He started Vasogenesis Inc (Boston MA), where he presently serves as the Chief Research and Medical Officer. He has authored 45 peer review publications, book chapters, and books in Vascular Surgery, and has been an invited speaker in USA and internationally.

Nagy Habib

Imperial College London, United Kingdom

Nagy Habib

Nagy Habib

Imperial College London, United Kingdom

For over three decades Nagy has been at the forefront of clinical research and clinical practice in cancer. He pioneered the first clinical trial in the use of adenovirus and plasmid for the treatment of liver cancer, as well as the use of plasmid gene therapy in hydrodynamic gene delivery. Nagy is a founder and was the Head of R&D of MiNA Therapeutics. Whilst at MiNA he was driving the development of an saRNA drug (a new class of medicines) which is currently being trialled in patients with liver cancer in eight UK centres, and sites in Singapore and Taiwan (OUTREACH study, ClinicalTrials.gov ID NCT02716012) and in a second trial in patients with solid tumours (TIMEPOINT study, ClinicalTrials.gov ID NCT 04105335) in the UK, USA, Europe, Singapore and Taiwan. He has published widely in gene therapy, stem cell therapy, oligonucleotides, endoscopy and surgery. Currently he is the CEO of Apterna Limited, a company focussed on novel oligonucleotide deliver. Previously Nagy was founder and Chairman of EMcision Limited (acquired by Boston Scientific Inc in 2018).

Participant Profile Analysis

62%
Clinical Practitioners

General practitioners, specialists in prosthodontics, endodontics, orthodontics, and implant dentistry

28%
Academic Researchers

University faculty, postdoctoral researchers, PhD candidates, and postgraduate residents

10%
Industry Professionals

Technology company representatives, dental laboratory technicians, biomedical engineers

Geographic Distribution

38%
Europe
27%
Asia-Pacific
22%
North America
13%
Other Regions

Explore Other Past Conference Editions

Review proceedings and outcomes from previous years of the conference series

2025 London, UK 2024 London, UK 2023 London, UK View All Archives

Join the Next Edition

Continue this tradition of scientific excellence. Registration is now open for our upcoming edition.

View Current Conference Register Now
Watsapp